David Bharucha - 15 Feb 2022 Form 3 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Chief Medical Officer
Issuer symbol
MIST
Report date
15 Feb 2022
Net transaction value
$0
Source evidence 4 source fields
Form type
3
Accepted by SEC
17 Feb 2022, 15:46:05 UTC
Next filing
05 Dec 2022
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Minio, Attorney-in-Fact

Key filing fact

David Bharucha filed Form 3 for Milestone Pharmaceuticals Inc. (MIST) on 17 Feb 2022.

Key facts

  • This page summarizes David Bharucha's Form 3 filing for Milestone Pharmaceuticals Inc. (MIST).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Feb 2022, 15:46.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

SEC remarks

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .